Telomerase activity in non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• High telomerase activity is a hallmark of many cancers, including lung cancer.
• Investigating telomerase as a prognostic marker in non-small cell lung cancer (NSCLC) is crucial for treatment stratification.

Purpose of the Study:

• To evaluate telomerase activity as a prognostic factor in patients diagnosed with non-small cell lung cancer (NSCLC).

Main Methods:

• Telomerase activity was measured using the telomeric repeat amplification protocol (TRAP) in 47 NSCLC tissue specimens.
• A control group of 30 non-cancerous lung parenchyma specimens was used for comparison.
• Analysis included correlations with patient demographics, tumor characteristics, and survival rates.

Main Results:

• Telomerase activity was significantly elevated in NSCLC tissues compared to non-cancerous lung tissue.
• No significant association was found between telomerase activity and patient age, gender, smoking status, tumor histology, or TNM staging.
• Telomerase activity did not correlate with two-year survival rates in NSCLC patients (p = 0.326).
• A positive association was observed between higher telomerase activity and poorly differentiated tumors (G3) versus moderately differentiated tumors (G2) (p = 0.008).
• Increased telomerase activity in non-tumorous lung parenchyma correlated with leukocyte infiltration (p = 0.0001).

Conclusions:

• Telomerase activity levels in NSCLC specimens are not associated with patient survival.
• A significant correlation exists between higher telomerase activity and poor tumor differentiation (G3) in NSCLC.
• Telomerase activity in adjacent lung tissue may be influenced by inflammatory processes.